Impact of TP53 functional mutation type on clinical outcomes of advanced breast cancer patients

被引:0
|
作者
Stjepanovic, N. [1 ]
Garg, S. [1 ]
Berman, H. [1 ]
Warr, D. [1 ]
Amir, E. [1 ]
Cescon, D. [1 ]
Elser, C. [1 ]
Wang, L. [1 ]
Kamel-Reid, S. [1 ]
Siu, L. [1 ]
Bedard, P. L. [1 ]
Stockley, T. [1 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
关键词
D O I
10.1158/1538-7445.SABCS16-P2-05-19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-05-19
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients
    Powell, BL
    Bydder, S
    Grieu, F
    Gnanasampanthan, G
    Elsaleh, H
    Seshadri, R
    Berns, EMJJ
    Iacopetta, B
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (01) : 65 - 68
  • [22] TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
    A Petitjean
    M I W Achatz
    A L Borresen-Dale
    P Hainaut
    M Olivier
    Oncogene, 2007, 26 : 2157 - 2165
  • [23] TP53 mutations in familial breast cancer: Functional aspects
    Gasco, M
    Yulug, IG
    Crook, T
    HUMAN MUTATION, 2003, 21 (03) : 301 - 306
  • [24] TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
    Petitjean, A.
    Achatz, M. I. W.
    Borresen-Dale, A. L.
    Hainaut, P.
    Olivier, M.
    ONCOGENE, 2007, 26 (15) : 2157 - 2165
  • [25] Impact of TP53 status and functional classification on molecular profiles in breast cancer subtypes
    Garg, Swati
    Sukhai, Mahadeo A.
    Misyura, Maksym
    Thomas, Mariam
    Zhang, Tong
    Siu, Lillian L.
    Bedard, Philippe L.
    Stockley, Tracy L.
    Kamel-Reid, Suzanne
    CANCER RESEARCH, 2016, 76
  • [26] The Impact of TP53 Mutation and Tumor Mutation Number on Outcomes in Patients with Stage I Non Small Cell Lung Cancer
    Zheng, S.
    Xia, J.
    Zeng, F.
    Huang, L.
    Li, F.
    Zhu, H.
    Liao, G.
    Lin, Z.
    Zhou, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1058 - S1058
  • [27] Clinical impact of TP53 functional mutations in patients with metastatic colorectal cancer treated with bevacizumab and chemotherapy
    Ruzzo, Annamaria
    Graziano, Francesco
    Palladino, Silvia
    Fischer, Nicholas W.
    Catalano, Vincenzo
    Giordani, Paolo
    Malkin, David
    Tamburrano, Tiziana
    Patriti, Alberto
    Petrelli, Filippo
    Sarti, Donatella
    Chiari, Rita
    ONCOLOGIST, 2024,
  • [28] TP53 germline mutation testing in early onset breast cancer
    Conte, B.
    Varesco, L.
    Iacono, G.
    Poggio, F.
    Blondeaux, E.
    Levaggi, A.
    D'Alonzo, A.
    Bighin, C.
    Giraudi, S.
    Vaglica, M.
    Pronzato, P.
    Del Mastro, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Impact of TP53 mutations in Triple Negative Breast Cancer
    Zahi I. Mitri
    Nour Abuhadra
    Shaun M. Goodyear
    Evthokia A. Hobbs
    Andy Kaempf
    Alastair M. Thompson
    Stacy L. Moulder
    npj Precision Oncology, 6
  • [30] Impact of TP53 mutations in Triple Negative Breast Cancer
    Mitri, Zahi, I
    Abuhadra, Nour
    Goodyear, Shaun M.
    Hobbs, Evthokia A.
    Kaempf, Andy
    Thompson, Alastair M.
    Moulder, Stacy L.
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)